Zhejiang Benli Technology Co., Ltd. (SHE:301065)

Market Cap	1.87B -23.4%
Revenue (ttm)	661.61M +1.6%
Net Income	81.98M +17.2%
EPS	0.79 +16.2%
Shares Out	103.98M
PE Ratio	22.79
Forward PE	n/a
Dividend	0.30 (1.67%)
Ex-Dividend Date	Jun 16, 2026

Volume	1,239,450
Open	18.15
Previous Close	18.09
Day's Range	17.92 - 18.33
52-Week Range	16.60 - 25.17
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Zhejiang Benli Technology

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl N,N-dimethylaminoacrylate, 2,6-Dichlorofluorobenzene, and 3-(2-Ethylene...

• Industry: Chemicals
• Sector: Materials
• Founded: 2011
• Employees: 472
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301065

Financial Performance

In 2025, Zhejiang Benli Technology's revenue was 638.53 million, a decrease of -9.92% compared to the previous year's 708.83 million. Earnings were 78.83 million, an increase of 22.08%.

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Nov 13, 2026

Data Sources Report a data error